Relationship between regular cervical cancer screening and social background in Japan during the COVID-19 pandemic

Abstract

Abstract Background: Among Organization for Economic Co-operation and Development countries, Japan has one of the lowest cervical cancer screening rates. The cancer screening rate has reportedly worsened with the coronavirus disease of 2019 (COVID-19) pandemic. This study investigated the COVID-19 history and socioeconomic background of people who did not undergo on-time cervical cancer screening (CCS) during the two years of COVID-19-related restrictions in Japan. Methods: We used data from the Japan COVID-19 and Society Internet Survey, a nationwide, internet-based, self-report, cohort observational study conducted in 2022. The outcome variable was identified by asking whether the respondent had undergone on-time CCS within the last two years. This study used multivariate log-binomial regression models to evaluate inequalities during regular checkups for CCS. Adjusted prevalence ratios (APRs) with 95% confidence intervals (CIs) were estimated to incorporate socioeconomic background variables. Results: Of 12,066 respondents, 6469 (53.6%) had yet to undergo CCS within two years. The prevalence ratio (PR) of on-time CCS was 0.70 (95% CI: 0.63–0.79) for those in their 20s and 0.78 (95%CI:0.70-0.87) for those in their 60s, compared to their 40s. Moreover, socioeconomic inequities were found in the following groups: unemployed/student, unmarried, high school graduate or lower, and household income below 4 million yen. PR of on-time CCS with a history of COVID-19, unvaccinated status, or fear of COVID-19 was not significantly different from that of respondents who underwent CCS. However, the PR of those who had not undergone on-time CCS was significantly lower than that of respondents who had undergone breast cancer screening (PR: 0.29, 95% CI: 0.28–0.31). Conclusion: the relationship between socioeconomic inequalities and CCS hesitancy was prevalent among the younger respondents. Our findings will help policymakers identify problems and strategies to improve CCS screening rates in Japan.